Editorial: changes in renal function and bone mineral density after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in chronic hepatitis B patients—author's reply

LINKED CONTENT This article is linked to Papatheodoridis et al papers. To view these articles, visit https://doi.org/10.1111/apt.17093 and https://doi.org/10.1111/apt.17117

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2022-09, Vol.56 (5), p.918-919
Main Author: Papatheodoridis, George V.
Format: Article
Language:English
Subjects:
Bone mineral density
Hepatitis B
Renal function
Tenofovir
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:LINKED CONTENT This article is linked to Papatheodoridis et al papers. To view these articles, visit https://doi.org/10.1111/apt.17093 and https://doi.org/10.1111/apt.17117
ISSN:0269-2813
1365-2036
DOI:10.1111/apt.17146